Peripheral Arterial Disease Trial, Recruiting (NCT05698628)

Peripheral Arterial Disease Trial, Recruiting NCT05698628 Sponsor: Min-Seok Kim Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05698628 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 19 years or older
People who have severe heart failure (cardiogenic shock) that has not responded to treatment, and who are currently on a heart-lung bypass support machine called a VA-ECMO connected through the leg (peripheral VA-ECMO)
People who are able to give their consent to take part, or who have someone authorised to give consent on their behalf

Who may not be able to join:

People for whom consent cannot be given — either by the person themselves or by an authorised decision-maker
People who are currently pregnant, have given birth within the last 30 days, or are breastfeeding
People who are using the VA-ECMO support machine for a reason other than severe heart failure (cardiogenic shock)
People who have a serious blood clotting disorder
People who already have permanent, irreversible reduced blood flow to a limb that requires a procedure or surgery, including those previously diagnosed with a blood vessel narrowing condition called atherosclerosis obliterans (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Min-Seok Kim, Asan Medical Center

Phone: 82-2-3010-3948

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05698628

Sponsor: Min-Seok Kim

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 82-2-3010-3948

More information: https://clinicaltrials.gov/study/NCT05698628

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 19 years or older
People who have severe heart failure (cardiogenic shock) that has not responded to treatment, and who are currently on a heart-lung bypass support machine called a VA-ECMO connected through the leg (peripheral VA-ECMO)
People who are able to give their consent to take part, or who have someone authorised to give consent on their behalf

Who may not be able to join:

People for whom consent cannot be given — either by the person themselves or by an authorised decision-maker
People who are currently pregnant, have given birth within the last 30 days, or are breastfeeding
People who are using the VA-ECMO support machine for a reason other than severe heart failure (cardiogenic shock)
People who have a serious blood clotting disorder
People who already have permanent, irreversible reduced blood flow to a limb that requires a procedure or surgery, including those previously diagnosed with a blood vessel narrowing condition called atherosclerosis obliterans (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Min-Seok Kim

Registry

ClinicalTrials.gov

Start date

28 April 2023

Est. completion

28 February 2027

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Limb ischemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov